Skip to main content

Table 3 Causative mutations and putative pathogenic variants identified in this study

From: Targeted next generation sequencing for molecular diagnosis of Usher syndrome

Patient

Clinical type

Gene

Exon

Nucleotide variant

Protein variant

Reference

Segregation analysis

Patients with two pathogenic mutations in the same gene

RP-807

USH2

MYO7A

40

c.5516 T > C

p.Leu1839Pro

Novel. UV3

Yes

MYO7A

27

c.3503G > A

p.Arg1168Gln

Novel. UV3

 

RP-808¶

USH1

CDH23

47

c.6059-9G > A

---

von Brederlow et al., (2002) [40]

No

CDH23

10

c.871G > A

p.Gly291Arg

Novel. UV3

 

RP-890

USH3

USH2A

26

c.5278delG

p.Asp1760Metfs*10

Garcia-Garcia et al., (2011) [41]

No

USH2A

26

c.5278delG

p.Asp1760Metfs*10

Garcia-Garcia et al., (2011) [41]

 

RP-1182

USH1

PCDH15

22_23

Duplication exons 22_23

---

Novel. UV4

No

PCDH15

22_23

Duplication exons 22_23

---

Novel. UV4

 

RP-1183

USH1

CDH23

26

c.3016G > A

p.Glu1006Lys

Schultz et al., (2011) [42]

No

CDH23

26

c.3016G > A

p.Glu1006Lys

Schultz et al., (2011) [42]

 

RP-1234

USH1

MYO7A

43

c.5884delTTCT

p.Phe1962Leufs*7

Novel. UV4

Yes

MYO7A

43

c.5884delTTCT

p.Phe1962Leufs*7

Novel. UV4

 

RP-1237

USH1

CDH23

46

c.6049G > A

p.Gly2017Ser

Roux et al., (2006) [43]

No

CDH23

46

c.6049G > A

p.Gly2017Ser

Roux et al., (2006) [43]

 

RP-1374¶

USH1

PCDH15

2

c.7C > T

p.Arg3*

Ahmed et al., (2001) [44]

Yes

PCDH15

27

c.3717 + 2dupT

---

Jaijo et al., (2012) [45]

 

RP-1422

USH1

MYO7A

43

c.5944G > A

p.Gly1982Arg

Riazuddin et al., (2008) [46]

Yes

MYO7A

43

c.5944G > A

p.Gly1982Arg

Riazuddin et al., (2008) [46]

 

RP-1522¶

USH2

USH2A

13

c.2299delG

p.Glu767Serfs*21

Liu et al., (1999) [47]

No

USH2A

20

Deletion exon 20

---

Novel. UV4

 

RP-1551

USH1

PCDH15

27

c.3511delA

p.Asp1172Ilefs*13

Novel. UV4

Yes

PCDH15

27

c.3511delA

p.Asp1172Ilefs*13

Novel. UV4

 

RP-1614¶

USH1

MYO7A

44

c.6025delG

p.Ala2009Profs*32

Bharadwaj et al., (2000) [48]

No

MYO7A

40

c.5537C > A

p.Pro1846His

Novel. UV3

 

RP-1760¶

USH2

USH2A

55

c.10888delA

p.Gly3631Valfs*43

Novel. UV4

No

USH2A

13

c.2296 T > C

p.Cys766Arg

Glöcke et al., (2013) [35]

 

RP-1781

USH2

CDH23

29

Duplication exon 29

---

Novel. UV4

No

CDH23

68

c.9569C > T

p.Ala3190Val

Novel. UV3

 

RP-1791

USH1

MYO7A

20

c.2283-1G > T

---

Roux et al., (2006) [43]

Yes

MYO7A

28

c.3594C > A

p.Cys1198*

Roux et al., (2011) [43]

 

RP-1802

USH2

USH2A

63

c.13811 + 2 T > G

---

Besnard et al., (2014) [37]

No

USH2A

50

c.9799 T > C

p.Cys3267Arg

Aller et al., (2006) [49]

 

RP-1835

USH2

USH2A

57

c.11065C > T

p.Arg3689*

Le Quesne Stabej et al., 2012 [50]

Yes

USH2A

22

c.4758 + 3A > G

---

Novel. UV3

 

RP-1864

USH2

MYO7A

6

c.494C > T

p.Thr165Met

Ouyang et al., (2005) [51]

No

MYO7A

6

c.494C > T

p.Thr165Met

Ouyang et al., (2005) [51]

 

RP-1895

USH2

GPR98

79_83

Duplication exons 79_83

---

Besnard et al., (2012) [52]

No

GPR98

79_83

Duplication exons 79_83

---

Besnard et al., (2012) [52]

 

RP-1904

USH2

GPR98

11

c.2145_2149delGTTTT

p.Leu715Phefs*6

Novel. UV4

Yes

GPR98

14

c.2612delG

p.Gly871Glufs*8

Novel. UV4

 

RP-1910

USH1

CDH23

60

c.8722 + 1delG

---

Oshima et al., (2008) [53]

Yes

CDH23

60

c.8722 + 1delG

---

Oshima et al., (2008) [53]

 

RP-1924

USH1

MYO7A

39

c.5392C > T

p.Gln1798*

Janecke et al., (1999) [54]

Yes

MYO7A

27

c.3503G > A

p.Arg1168Gln

Novel. UV3

 

RP-1927

USH2

USH2A

21

c.4474G > T

p.Glu1492*

Bernal et al., (2005) [55]

Yes

USH2A

2

c.269A > G

p.Tyr90Cys

Novel. UV3

 

RP-1948

USH1

MYO7A

7

C.707 T > A

p.Leu236Gln

Novel. UV3

No

MYO7A

42

c.5749G > T

p.Glu1917*

Jacobson et al., (2009) [56]

 

RP-1960

USH2

USH2A

25

c.5167G > C

p.Gly1723Arg

Novel. UV3

No

USH2A

7

c.1214delA

p.Asn405Ilefs*3

Bernal et al., (2005) [55]

 

Patients with three pathogenic mutations in two different genes

RP-1847

USH2

USH2A

62

c.12067-2A > C

---

Kaiserman et al., (2007) [57]

Yes

USH2A

14

Deletion exon 14

---

Glöckle et al., (2013) [35]

 

USH1G

2

c.805C > T

p.Arg269*

Novel. UV4

 

RP-1923

USH2

USH2A

62

c.12093delC

p.Tyr4031*

Garcia-Garcia et al., (2011) [41]

No

USH2A

44

Deletion exon 44

---

Glöckle et al., (2013) [35]

 

DFNB31

9

c.2234G > A

p.Arg745His

Novel. UV3

 

Patients with only one pathogenic mutation

RP-1455

USH1

USH2A

28

c.5666A > G

p.Asp1889Gly

Novel. UV3

No

RP-1496

USH3

GPR98

19

c.3443G > A

p.Gly1148Asp

Novel. UV3

No

RP-1741

USH2

USH2A

PE40

c.7592-2144A > G

---

Vaché et al., (2012) [58]

No

RP-1929

USH2

GPR98

58

c.11974G > A

p.Asp3992Asn

Novel. UV3

No

RP-1953

USH2

USH1C

18

c.1859G > T

p.Arg620Leu

Ouyang et al., (2002) [59]

No

Patients with pathologic mutations in different genes

RP-1426¶

USH1

MYO7A

49

c.6610G > C

p.Ala2204Pro

Jaijo et al., (2007) [60]

Yes

CDH23

39

c.5068-2A > T

---

Novel. UV4

 

RP-1950

USH2

USH2A

70

c.2299delG

p.Glu767Serfs*21

Liu et al., (1999) [47]

No

GPR98

70

c.14278C > T

p.Pro4760Ser

Novel. UV3

 
  1. Patients previously included in the test group are marked with ¶.
  2. Novel variants are marked in bold.
  3. PE: Pseudoexon 40.